Page last updated: 2024-11-03

probenecid and Movement Disorders

probenecid has been researched along with Movement Disorders in 6 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, H1
Lerner, PI1
Weinstein, L1
Pind, K1
Faurbye, A1
Chase, TN2
Cramer, H1
Ng, LK1
Cohen, DJ1
Shaywitz, BA1
Johnson, WT1
Bowers, M1
Barbeau, A1

Reviews

2 reviews available for probenecid and Movement Disorders

ArticleYear
Drug-induced extrapyramidal disorders.
    Research publications - Association for Research in Nervous and Mental Disease, 1972, Volume: 50

    Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopa

1972
[Biochemical and clinical correlations in Parkinson's disease].
    Revue neurologique, 1972, Volume: 127, Issue:2

    Topics: Brain; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Humans; Movement Disorders; Norepinephri

1972

Other Studies

4 other studies available for probenecid and Movement Disorders

ArticleYear
Neurotoxicity and "massive" intravenous therapy with penicillin. A study of possible predisposing factors.
    Archives of internal medicine, 1967, Volume: 120, Issue:1

    Topics: Adolescent; Adult; Aged; Central Nervous System; Central Nervous System Diseases; Child; Child, Pres

1967
Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.
    Acta psychiatrica Scandinavica, 1970, Volume: 46, Issue:4

    Topics: Dopamine; Humans; Hydroxyindoleacetic Acid; Movement Disorders; Phenylacetates; Probenecid; Schizoph

1970
Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.
    Archives of neurology, 1973, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Aged; Cerebellar Diseases; Child; Cyclic AMP; Dihydroxyphenylalanine; Female; Hom

1973
Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Archives of general psychiatry, 1974, Volume: 31, Issue:6

    Topics: Autistic Disorder; Brain; Child; Child, Preschool; Diagnosis, Differential; Dopamine; Electroencepha

1974
chemdatabank.com